Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

• Κύριοι συγγραφείς: M. Gattinara (Συγγραφέας), E. Valcamonica (Συγγραφέας), A. Salmaso (Συγγραφέας), B. Teruzzi (Συγγραφέας), A. Lurati (Συγγραφέας), I. Pontikaki (Συγγραφέας), V. Gerloni (Συγγραφέας), G. De Marco (Συγγραφέας), F. Fantini (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: PAGEPress Publications, 2011-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Objectives: To evaluate, in long-term open label prospective study, infliximab as therapeutic choice for Juvenile Idiopathic Arthritis (JIA) non responsive to conventional therapy. Methods: We enrolled to treat with infliximab 78 JIA patients (66 females, 12 males): the mean age was 20.7±7.1 years (...